Authors:
ALMAYOUF SM
SILVERMAN ED
FELDMAN BM
THORNER P
LAXER RM
Citation: Sm. Almayouf et al., CYCLOSPORINE IN THE TREATMENT OF AN UNUSUAL CASE OF JUVENILE SYSTEMIC-SCLEROSIS, Journal of rheumatology, 25(4), 1998, pp. 791-793
Authors:
GAZARIAN M
FELDMAN BM
BENSON LN
GILDAY DL
LAXER RM
SILVERMAN ED
Citation: M. Gazarian et al., ASSESSMENT OF MYOCARDIAL PERFUSION AND FUNCTION IN CHILDHOOD SYSTEMICLUPUS-ERYTHEMATOSUS, The Journal of pediatrics, 132(1), 1998, pp. 109-116
Authors:
SPIEGEL LR
SCHNEIDER R
LANG BA
BIRDI N
SILVERMAN ED
LAXER RM
FELDMAN BM
Citation: Lr. Spiegel et al., EARLY PREDICTORS OF POOR OUTCOME IN SYSTEMIC-ONSET JUVENILE RHEUMATOID-ARTHRITIS - A MULTICENTER COHORT STUDY, Arthritis and rheumatism, 41(9), 1998, pp. 96-96
Authors:
BRUNNER HI
FELDMAN BM
BOMBARDIER C
SCHNEIDER R
SILVERMAN ED
Citation: Hi. Brunner et al., THE SLEDAI, SLAM AND BILAG ARE SENSITIVE MEASURES TO EVALUATE CLINICAL-CHANGE IN CHILDHOOD-ONSET SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE), Arthritis and rheumatism, 41(9), 1998, pp. 1385-1385
Citation: Bm. Feldman et Eh. Giannini, PEDIATRIC RHEUMATOLOGY IN THE 21ST-CENTURY - WHERES THE COMMON-SENSE - REPLY, Journal of rheumatology, 24(9), 1997, pp. 1856-1856
Authors:
RIDER LG
FELDMAN BM
PEREZ MD
RENNEBOHM RM
LINDSLEY CB
ZEMEL LS
WALLACE CA
BALLINGER SH
BOWYER SL
REED AM
PASSO MH
KATONA IM
MILLER FW
LACHENBRUCH PA
Citation: Lg. Rider et al., DEVELOPMENT OF VALIDATED DISEASE-ACTIVITY AND DAMAGE INDEXES FOR THE JUVENILE IDIOPATHIC INFLAMMATORY MYOPATHIES .1. PHYSICIAN, PARENT, ANDPATIENT GLOBAL ASSESSMENTS, Arthritis and rheumatism, 40(11), 1997, pp. 1976-1983
Citation: Bm. Feldman et Eh. Giannini, WHERES THE EVIDENCE - PUTTING CLINICAL SCIENCE INTO PEDIATRIC RHEUMATOLOGY, Journal of rheumatology, 23(9), 1996, pp. 1502-1504
Authors:
FELDMAN BM
REICHLIN M
LAXER RM
TARGOFF I
STEIN LD
SILVERMAN ED
Citation: Bm. Feldman et al., CLINICAL-SIGNIFICANCE OF SPECIFIC AUTOANTIBODIES IN JUVENILE DERMATOMYOSITIS, Journal of rheumatology, 23(10), 1996, pp. 1794-1797
Authors:
FELDMAN BM
BIRDI N
BOONE JE
DENT PB
DUFFY CM
ELLSWORTH JE
LANG BA
LAXER RM
LEWKONIA RM
MALLESON PN
OEN KG
PAQUIN JD
ROSENBERG AM
SCHNEIDER R
SILVERMAN ED
Citation: Bm. Feldman et al., SEASONAL ONSET OF SYSTEMIC-ONSET JUVENILE RHEUMATOID-ARTHRITIS, The Journal of pediatrics, 129(4), 1996, pp. 513-518
Authors:
MUZAFFER MA
LIN MKS
FELDMAN BM
BOMZE S
MCCRINDLE B
LAXER RM
SCHNEIDER R
SILVERMAN ED
Citation: Ma. Muzaffer et al., SECRETORY PHOSPHOLIPASE-A2 (SPLA2) IN KAWASAKI-DISEASE AS A PREDICTIVE MARKER OF CORONARY-DISEASE, Arthritis and rheumatism, 39(9), 1996, pp. 1246-1246
Authors:
GAZARIAN M
BOMBARDIER C
IBANEZ D
FELDMAN BM
WRIGHT JG
KOREN G
Citation: M. Gazarian et al., DEVELOPMENT OF AN ADVERSE EVENT INDEX FOR USE IN CLINICAL-TRIALS OF PHARMACOTHERAPIES IN PEDIATRIC RHEUMATIC DISEASES .1. DEVELOPMENT OF THE SYMPTOM DOMAIN, Arthritis and rheumatism, 39(9), 1996, pp. 1248-1248
Authors:
RIDER LG
FELDMAN BM
RENNEBOHM RM
LINDSLEY CB
REED AM
ZEMEL LS
BALLINGER SH
BOWYER SL
PEREZ ME
LOVELL DJ
PASSO MH
WALLACE CA
VOGELGESANG SA
KATONA IM
SUNDEL BP
KREDICH DW
MILLER FW
LACHENBRUCH PA
Citation: Lg. Rider et al., PHYSICIAN GLOBAL ASSESSMENTS OF DISEASE-ACTIVITY (DA) AND DISEASE CHRONICITY (DC) IN JUVENILE DERMATOMYOSITIS (JDM) - VALIDATION AND CONTRIBUTING FACTORS, Arthritis and rheumatism, 39(6), 1996, pp. 22-22
Authors:
FELDMAN BM
AYLINGCAMPOS A
LUY L
STEVENS D
SILVERMAN ED
LAXER RM
Citation: Bm. Feldman et al., MEASURING DISABILITY IN JUVENILE DERMATOMYOSITIS - VALIDITY OF THE CHILDHOOD HEALTH ASSESSMENT QUESTIONNAIRE, Journal of rheumatology, 22(2), 1995, pp. 326-331
Citation: Bm. Feldman et al., HOW SHOULD EXCESS ADMISSION LABORATORY TEST UTILIZATION BE CURTAILED - PEDIATRICIANS PREFERENCES, Clinical and investigative medicine, 18(6), 1995, pp. 502-509
Citation: Bm. Feldman et Jp. Szalai, TOWARDS A MORE ETHICAL CLINICAL-TRIAL DESIGN - THE RANDOMIZED PLACEBOPHASE DESIGN (RPPD), Arthritis and rheumatism, 38(9), 1995, pp. 146-146